Find Paid Research Studies in Wyoming

Conditions:   Adult Giant Cell Glioblastoma;   Adult Glioblastoma;   Adult Gliosarcoma;   Fatigue
Interventions:   Drug: armodafinil;   Other: Placebo
Sponsors:   Alliance for Clinical Oncology Trials;   Cancer and Leukemia Group B;   National Cancer Institute (NCI)
Recruiting - verified January 2013

Condition:   Colorectal Cancer
Interventions:   Drug: bevacizumab [Avastin];   Drug: leucovorin;   Drug: 5-fluorouracil;   Drug: irinotecan;   Drug: oxaliplatin;   Drug: capecitabine [Xeloda];   Drug: fluoropyrimidine-based chemotherapy
Sponsors:   Hoffmann-La Roche;   Hoffmann-La Roche
Recruiting - verified June 2013

Condition:   Small Cell Lung Carcinoma
Interventions:   Drug: LY2940680;   Drug: Carboplatin;   Drug: Etoposide;   Drug: Placebo
Sponsors:   Eli Lilly and Company;   Eli Lilly and Company
Recruiting - verified June 2013

Conditions:   Epilepsy;   Monotherapy
Interventions:   Drug: Lacosamide;   Drug: Carbamazepine-Controlled Release
Sponsors:   UCB, Inc.;   UCB BIOSCIENCES GmbH;   EDEV S.À.R.L
Recruiting - verified June 2013

Conditions:   Light Chain Deposition Disease;   Smoldering Multiple Myeloma
Interventions:   Other: clinical observation;   Drug: lenalidomide;   Other: laboratory biomarker analysis
Sponsors:   National Cancer Institute (NCI);   National Cancer Institute (NCI)
Recruiting - verified May 2013

Conditions:   brca1 Mutation Carrier;   brca2 Mutation Carrier;   Breast Cancer
Interventions:   Dietary Supplement: cholecalciferol;   Other: placebo
Sponsors:   Southwest Oncology Group;   Southwest Oncology Group;   National Cancer Institute (NCI)
Recruiting - verified May 2013

Conditions:   Adult Acute Lymphoblastic Leukemia in Remission;   B-cell Adult Acute Lymphoblastic Leukemia;   L1 Adult Acute Lymphoblastic Leukemia;   L2 Adult Acute Lymphoblastic Leukemia;   Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia;   Recurrent Adult Acute Lymphoblastic Leukemia;   T-cell Adult Acute Lymphoblastic Leukemia;   Untreated Adult Acute Lymphoblastic Leukemia
Interventions:   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: vincristine sulfate;   Drug: dexamethasone;   Drug: dasatinib;   Drug: cytarabine;   Drug: methotrexate;   Biological: filgrastim;   Drug: methylprednisolone;   Drug: leucovorin calcium;   Drug: prednisone;   Radiation: total-body irradiation;   Drug: etoposide;   Procedure: allogeneic hematopoietic stem cell transplantation;   Procedure: peripheral blood stem cell transplantation;   Drug: sirolimus;   Drug: tacrolimus;   Other: laboratory biomarker analysis
Sponsors:   National Cancer Institute (NCI);   National Cancer Institute (NCI)
Recruiting - verified June 2013

Condition:   Prostate Cancer
Interventions:   Drug: bicalutamide;   Drug: flutamide;   Radiation: radiation therapy
Sponsors:   Radiation Therapy Oncology Group;   Radiation Therapy Oncology Group;   National Cancer Institute (NCI);   Cancer and Leukemia Group B
Recruiting - verified June 2013